Literature DB >> 34653356

Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial".

Thomas W Samuelson1, Inder Paul Singh2, Blake K Williamson3, Heather Falvey4, L Jay Katz4, Won Chan Lee5, Dawn Odom6, David McSorley6.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34653356     DOI： 10.1016/j.ajo.2021.09.039

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  2 in total

1.  iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control.

Authors:  Fritz H Hengerer; Gerd U Auffarth; Ina Conrad-Hengerer
Journal:  Adv Ther       Date:  2022-02-03       Impact factor: 3.845

2.  Surgical Outcomes of Combined 2nd-Generation Trabecular Microbypass (iStent Inject) and Cataract Surgery for the Treatment of Primary Open-Angle Glaucoma in the Saudi Population.

Authors:  Ahmed Al Habash; Wael Otaif
Journal:  Ophthalmol Ther       Date:  2021-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.